A multicenter randomized controlled trial evaluating a new radiofrequency ablation system in the treatment of primary great saphenous vein incompetence: Six-month results of the ACOART RF CLOSURE study

Abstract

Background

Radiofrequency ablation (RFA) has been recommended as the first-line treatment with primary great saphenous vein (GSV) incompetence. A multicenter randomized controlled trial was performed to evaluate the performance, efficacy, and safety of the new radiofrequency ablation system (AcoArt Cedar^TM) with ClosureFast^TM RFA system (Medtronic).

Methods

Consecutive eligible patients with primary GSV incompetence were randomized 1:1 to treatment with AcoArt Cedar^TM or ClosureFast^TM at multiple sites. The primary endpoint was the total occlusion rate of GSV 6 months after the procedure. Secondary outcomes included device success, immediate technical success, performance evaluation of the devices, and the mean change of the Revised Venous Clinical Severity Score (VCSS) and Aberdeen Varicose Vein Questionnaire (AVVQ) scores from baseline to 6 months post-treatment. Safety endpoint was device-related adverse events (AEs). All adverse events were recorded in the study.

Results

A total of 188 eligible patients were randomly assigned to treatment with AcoArt Cedar^TM or ClosureFast^TM. All patients achieved 100% device and immediate technical success. The performance of the RFA catheter and generator was evaluated as excellent for both groups. The total GSV occlusion rates at 6 months were 97.78% (88/90) versus 98.86% (87/88) for AcoArt Cedar^TM and ClosureFast^TM, respectively (p = 1.000). Changes in AVVQ and VCSS scores from baseline to 6 months after treatment were similar in the two groups: AVVQ (p = 0.802) and VCSS (p = 0.984). Procedure-related adverse events occurred in 9.6% (9/94) versus 7.5% (7/93) of patients, for AcoArt Cedar^TM and ClosureFast^TM, respectively (p = 0.9928). No device-related AEs or SAEs were found.

Conclusion

The AcoArt Cedar^TM is a device associated with non-inferior effectiveness and safety compared to ClosureFast^TM, with similar complete occlusion rates in the GSV with a low incidence of AEs.

Trial registry name

ClinicalTrials.gov; URL: https://clinicaltrials.gov/study/NCT04658901?term=NCT04658901&rank=1; registration number: NCT04658901.

Keywords

radiofrequency ablation primary great saphenous vein incompetence varicose veins randomized controlled trial

Get full access to this article

View all access options for this article.

References

Eberhardt

Raffetto

. Chronic venous insufficiency. Circulation 2014; 130(4): 333–346.

Rhodes

Gloviczki

Canton

, et al. Factors affecting clinical outcome following endoscopic perforator vein ablation. Am J Surg 1998; 176(2): 162–167.

Kim

Png

CYM

Sumpio

, et al. Defining the human and health care costs of chronic venous insufficiency. Semin Vasc Surg 2021; 34(1): 59–64.

Jin-song Jiang

. Progress and main points in treatment of lower extremities varicose veins. Chinese Journal of Practical Surgery 2021; 12: 4.

Chinese Society of Vascular Surgery, C.S.o.V.S., Chinese Medical Doctor Association, Chinese International Exchange and Promotion Association for Medical and Healthcare . Chinese guidelines for the diagnosis and treatment of chronic venous diseases. Chin J Med 2019; 99(39): 14.

De Maeseneer

Kakkos

Aherne

, et al. Editor’s choice - European society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg 2022; 63(2): 184–267.

Gloviczki

Lawrence

Wasan

, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. J Vasc Surg Venous Lymphat Disord 2024; 12(1): 101670.

Almeida

Kaufman

Göckeritz

, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol 2009; 20(6): 752–759.

Shepherd

Gohel

Brown

, et al. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins. Br J Surg 2010; 97(6): 810–818.

10.

Dermody

O’Donnell

Balk

. Complications of endovenous ablation in randomized controlled trials. J Vasc Surg Venous Lymphat Disord 2013; 1(4): 427–436.e1.

11.

Bitargil

Kilic

. Ablation of the great saphenous vein with F-care versus Closurefast endovenous radiofrequency therapy: double-blinded prospective study. Phlebology 2020; 35(8): 561–565.

12.

Zuniga

Hingorani

Ascher

, et al. Short-term outcome analysis of radiofrequency ablation using ClosurePlus vs ClosureFast catheters in the treatment of incompetent great saphenous vein. J Vasc Surg 2012; 55(4): 1048–1051.

13.

Garratt

Macdonald

Ruta

, et al. Towards measurement of outcome for patients with varicose veins. Qual Health Care 1993; 2(1): 5–10.

14.

Smith

Garratt

Guest

, et al. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg 1999; 30(4): 710–719.

15.

Vasquez

Rabe

McLafferty

, et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg 2010; 52(5): 1387–1396.

16.

Passman

McLafferty

Lentz

, et al. Validation of Venous Clinical Severity Score (VCSS) with other venous severity assessment tools from the American Venous Forum, National Venous Screening Program. J Vasc Surg 2011; 54(6 Suppl): 2S–9S.

17.

Sufian

Arnez

Labropoulos

, et al. Incidence, progression, and risk factors for endovenous heat-induced thrombosis after radiofrequency ablation. J Vasc Surg Venous Lymphat Disord 2013; 1(2): 159–164.

18.

Sermsathanasawadi

Pitaksantayothin

Puangpunngam

, et al. Incidence, risk factors, progression, and treatment of endovenous heat-induced thrombosis class 2 or greater after endovenous radiofrequency ablation. Dermatol Surg 2019; 45(4): 573–580.

19.

Nyamekye

Dattani

Hayes

, et al. A randomised controlled trial comparing three different radiofrequency technologies: short-term results of the 3-RF trial. Eur J Vasc Endovasc Surg 2019; 58(3): 401–408.

20.

Nyamekye

Pullen

Kelly

, et al. Six year extension study of patients from a randomised clinical trial comparing venefit, radiofrequency induced thermal therapy, and endovenous radiofrequency ablation for treatment of incompetent great saphenous veins. Eur J Vasc Endovasc Surg 2023; 66(1): 94–101.

21.

Proebstle

Alm

Göckeritz

, et al. Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg 2011; 54(1): 146–152.

22.

Proebstle

Alm

Göckeritz

, et al. Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br J Surg 2015; 102(3): 212–218.

23.

Calcagno

Rossi

. Effect of saphenous vein diameter on closure rate with ClosureFAST radiofrequency catheter. Vasc Endovasc Surg 2009; 43(6): 567–570.

24.

Woo

Kim

, et al. Outcome of ClosureFAST radiofrequency ablation for large-diameter incompetent great saphenous vein. Ann Surg Treat Res 2019; 96(6): 313–318.

25.

Kubat

Ünal

Geldi

, et al. What is the optimal treatment technique for great saphenous vein diameter of >/=10 mm? Comparison of five different approaches. Acta Chir Belg 2021; 121(2): 94–101.

26.

O'Banion

LAA

Siada

Cutler

, et al. Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: outcomes of a multicenter real-world experience. J Vasc Surg Venous Lymphat Disord 2022; 10(6): 1221–1228.

27.

Itoga

Rothenberg

Deslarzes-Dubuis

, et al. Incidence and risk factors for deep vein thrombosis after radiofrequency and laser ablation of the lower extremity veins. Ann Vasc Surg 2020; 62: 45–50.e2.

28.

Athavale

Monahan

Fukaya

. A systematic review on ablation techniques for larger saphenous veins in patients with symptomatic superficial venous disease. J Vasc Surg Venous Lymphat Disord 2024; 12(1): 101681.

29.

Cabrero Fernandez

Martinez Lopez

Hernandez Mateo

, et al. Prospective study of safety and effectiveness in the use of radiofrequency ablation for incompetent great saphenous vein >/=12 mm. J Vasc Surg Venous Lymphat Disord 2017; 5(6): 810–816.

30.

Bissacco

Malloggi

Domanin

, et al. Risk factors for short and long-term great saphenous vein recanalization in patients treated with endovenous radiofrequency ablation. Vascular 2023; 31(1): 131–141.